Blueberry Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Blueberry Therapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11308
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Blueberry Therapeutics Ltd (Blueberry Therapeutics) is a provider of nano medicines for the treatment of dermatological disorders. Its pipeline product portfolio includes BB2603-NCE, developed to treat onychomycosis and associated tinea pedis; BB2312 used for the treatment of Acne diseases, BB5000-NBE, to treat antimicrobial resistance, BB0109-NME developed for the treatment of inflammatory bowel disease and BB2702- NME used to treat atopic dermatitis. Blueberry Therapeutics provides peptides, protein and small molecules to treat infections. The company’s drug delivery system based on nanopolymer to self assembling. It operates through other pharmaceutical companies to develop new drug products. Blueberry Therapeutics is headquartered in Cheshire, the UK.

Blueberry Therapeutics Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Blueberry Therapeutics Raises USD12.7 Million in Series B Financing 10
Blueberry Therapeutics Raises USD4.4 Million in Venture Financing 11
Blueberry Therapeutics Raises USD1.75 Million in Financing Round 12
Partnerships 13
Blueberry Therapeutics Enters into Agreement with University of Sheffield and Sheffield Hallam University 13
Blueberry Therapeutics Enters into Agreement with University of Manchester for Antiflammatory Agents 14
Blueberry Therapeutics Enters into Agreement with University of Manchester and University of Liverpool 15
Licensing Agreements 16
Tecrea Enters into Licensing Agreement with Blueberry Therapeutics for Nanocin 16
Avacta Enters Into Licensing Agreement With Blueberry Therapeutics For Affimers 17
Blueberry Therapeutics Ltd – Key Competitors 18
Blueberry Therapeutics Ltd – Key Employees 19
Blueberry Therapeutics Ltd – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Product News 21
Jul 12, 2017: Blueberry to progress Nanomedicine platform to include novel Acne therapy 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Blueberry Therapeutics Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Blueberry Therapeutics Raises USD12.7 Million in Series B Financing 10
Blueberry Therapeutics Raises USD4.4 Million in Venture Financing 11
Blueberry Therapeutics Raises USD1.75 Million in Financing Round 12
Blueberry Therapeutics Enters into Agreement with University of Sheffield and Sheffield Hallam University 13
Blueberry Therapeutics Enters into Agreement with University of Manchester for Antiflammatory Agents 14
Blueberry Therapeutics Enters into Agreement with University of Manchester and University of Liverpool 15
Tecrea Enters into Licensing Agreement with Blueberry Therapeutics for Nanocin 16
Avacta Enters Into Licensing Agreement With Blueberry Therapeutics For Affimers 17
Blueberry Therapeutics Ltd, Key Competitors 18
Blueberry Therapeutics Ltd, Key Employees 19

List of Figures
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Blueberry Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tubacero S. de RL de CV:企業の戦略・SWOT・財務分析
    Tubacero S. de RL de CV - Strategy, SWOT and Corporate Finance Report Summary Tubacero S. de RL de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • FGL Sports Ltd.:企業の戦略・SWOT・財務情報
    FGL Sports Ltd. - Strategy, SWOT and Corporate Finance Report Summary FGL Sports Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Targa Resources Corp (TRGP):企業の財務・戦略的SWOT分析
    Targa Resources Corp (TRGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Goldman Sachs Private Wealth Management:企業の戦略・SWOT・財務分析
    Goldman Sachs Private Wealth Management - Strategy, SWOT and Corporate Finance Report Summary Goldman Sachs Private Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Nuo Therapeutics Inc (AURX):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuo Therapeutics Inc (Nuo Therapeutics), formerly Cytomedix, is a biomedical company that specializes in biodynamic therapies in the area of wound care. It focuses on commercializing cell-based technologies, which bind the regenerative capacity of the human body to trigger natural healing. T …
  • Insulet Corp (PODD):企業の財務・戦略的SWOT分析
    Insulet Corp (PODD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Avista Corp (AVA):企業の財務・戦略的SWOT分析
    Avista Corp (AVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Aveda Transportation and Energy Services Inc (AVE):石油・ガス:M&Aディール及び事業提携情報
    Summary Aveda Transportation and Energy Services Inc (Aveda), formerly Phoenix Oilfield Hauling Inc is an oilfield service provider that offers energy transportation and other energy related services. The company provides specialized transportation services and equipment for drilling, exploration, d …
  • TECSYS Inc. (TCS):企業の財務・戦略的SWOT分析
    TECSYS Inc. (TCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Vistra Energy Corp (VST):電力:M&Aディール及び事業提携情報
    Summary Vistra Energy Corp (Vistra Energy) is an investment holding company engaged in operation of integrated power business. The company through its subsidiaries is involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, and retail sales of e …
  • CVD Equipment Corp (CVV):企業の財務・戦略的SWOT分析
    Summary CVD Equipment Corp (CVD) is a technology company that manufactures, designs, and develops equipment and process solutions. The company’s product portfolio includes research and development equipments, gas and chemicals systems, production process system, automation equipments, cluster tools, …
  • Belden Inc (BDC):企業の財務・戦略的SWOT分析
    Belden Inc (BDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Teachers Mutual Bank Limited:企業の戦略的SWOT分析
    Teachers Mutual Bank Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • RISE Life Science Corp:企業のM&A・事業提携・投資動向
    RISE Life Science Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RISE Life Science Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Whirlpool Corporation:企業の戦略・SWOT・財務情報
    Whirlpool Corporation - Strategy, SWOT and Corporate Finance Report Summary Whirlpool Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Aster DM Healthcare-製薬・医療分野:企業M&A・提携分析
    Summary Aster DM Healthcare (Aster DM), formerly Dr Moopens Healthcare Management Services LLC is a healthcare service provider that provides patient care services. The company offers services such as cardiac surgery, mobile medical units, village adoption, early cancer detection centers and dialysi …
  • TelaDoc Inc (TDOC)-医療機器分野:企業M&A・提携分析
    Summary TelaDoc Inc (Teladoc) is a provider of telehealth services. The company offers short term prescription for amoxicillin, azithromycin, bactrim DS, augmentin, cipro, tessalon perles, flonase nasal spray, pyridium, prednisone and diflucan. It provides telehealth services for cold and flu sympto …
  • Biomunex Pharmaceuticals:製薬・医療:M&Aディール及び事業提携情報
    Summary Biomunex Pharmaceuticals (Biomunex) is a biopharmaceutical company that discovers and develops bispecific antibody therapeutics for the treatment of cancer. The company’s portfolio of pipeline products incldes BMX-101, which is developed as a novel immunotherapeutic treatment for relapsed an …
  • Sisaf Ltd-医療機器分野:企業M&A・提携分析
    Summary Sisaf Ltd (Sisaf) is a drug delivery company which designs and develops topical delivery systems for cosmetic, medical, and skin care applications. The company manufactures and markets products and drug delivery solutions using ProSilic, a nano-silicon technology platform. It offers ProSilli …
  • DBV Technologies SA (DBV):製薬・医療:M&Aディール及び事業提携情報
    Summary DBV Technologies SA (DBV) is a biopharmaceutical company that develops products for the diagnosis and treatment of food and pediatric allergies. The company develops and markets non-invasive epicutaneous delivery technology and products for healthcare markets. Its viaskin technology platform …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆